The Binding Site

The Binding Site The Specialist Protein Company

Binding Site, Part of Thermo Fisher Scientific, is committed to improving patient lives worldwide through education, collaboration and innovation. Binding Site provide diagnostic solutions that help doctors, clinicians and laboratory researchers across the globe diagnose and monitor blood cancers and immune system disorders. Founded by researchers at the University of Birmingham, Binding Site has

continued to build on its strong scientific foundations, supporting research and development within our field and responding to the changing needs of patients, researchers and clinicians for over 30 years. We are committed to working in collaboration with our partners and customers to lead the way in specialized medical diagnostics, ensuring we continue to make a difference together.

Diagnosing multiple myeloma early and monitoring it effectively can be challenging in everyday practice.A free new CME a...
25/08/2026

Diagnosing multiple myeloma early and monitoring it effectively can be challenging in everyday practice.

A free new CME activity with Medscape shares practical insights on applying current guidelines for multiple myeloma and its precursor conditions, including MGUS and smoldering myeloma.

๐Ÿ‘‰ Access the CME by searching โ€œMultiple Myeloma and Precursor Conditions: Guidelines for Diagnosis and Surveillanceโ€ on Medscape here: https://www.medscape.org/resource/multiple-myeloma/cme

Neurological symptoms can be an overlooked aspect of MGUS.Particularly, patients with IgM MGUS may be at increased risk ...
24/08/2026

Neurological symptoms can be an overlooked aspect of MGUS.

Particularly, patients with IgM MGUS may be at increased risk of neuropathy - reported in up to 30โ€“50% of cases.

Recognizing a Monoclonal Gammopathy as a potential underlying cause can support earlier, targeted management, addressing both the monoclonal disorder and neurological complications.

๐—Ÿ๐—ฒ๐—ฎ๐—ฟ๐—ป ๐—บ๐—ผ๐—ฟ๐—ฒ ๐—ฎ๐—ฏ๐—ผ๐˜‚๐˜ ๐— ๐—ผ๐—ป๐—ผ๐—ฐ๐—น๐—ผ๐—ป๐—ฎ๐—น ๐—š๐—ฎ๐—บ๐—บ๐—ผ๐—ฝ๐—ฎ๐˜๐—ต๐˜† ๐—ผ๐—ณ ๐—ก๐—ฒ๐˜‚๐—ฟ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฆ๐—ถ๐—ด๐—ป๐—ถ๐—ณ๐—ถ๐—ฐ๐—ฎ๐—ป๐—ฐ๐—ฒ (๐— ๐—š๐—ก๐—ฆ), ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐—ฑ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—ฑ๐—ถ๐—ฎ๐—ด๐—ป๐—ผ๐˜€๐˜๐—ถ๐—ฐ ๐—ฝ๐—ฎ๐˜๐—ต๐˜„๐—ฎ๐˜†, ๐—ถ๐—ป ๐—ผ๐˜‚๐—ฟ ๐˜„๐—ต๐—ถ๐˜๐—ฒ ๐—ฝ๐—ฎ๐—ฝ๐—ฒ๐—ฟ: https://www.thermofisher.com/bindingsite/wo/en/clinical-applications/monoclonal-gammopathies/mgcs.html?nocache&cid=0so_lnk_23072026_KH2R12

A huge thank you to everyone who visited our booth at ADLM 2026, attended our workshop, or joined one of our micro-lectu...
12/08/2026

A huge thank you to everyone who visited our booth at ADLM 2026, attended our workshop, or joined one of our micro-lectures.

It was fantastic to connect with so many customers, partners and colleagues, sharing ideas and discussing the future of multiple myeloma diagnostics and the role innovation can play in improving patient care๐Ÿ”ฌ

Thank you to everyone who helped make the week such a success. We look forward to continuing the conversations and working together to help make the world cleaner, healthier and safer.

Today, Binding Site will be leading a scientific workshop at 10:15am in Theatre 1 & our second micro-lecture at on boo...
29/07/2026

Today, Binding Site will be leading a scientific workshop at 10:15am in Theatre 1 & our second micro-lecture at on booth 3501 at 11:30am.

Our scientific workshop is focused on the evolution of monoclonal protein diagnostics to include the EXENTโ„ข System โ€“ a breakthrough in monoclonal gammopathy assessment.

The session will explore how the EXENT System addresses limitations in conventional electrophoretic-based methodologies, how it can enhance laboratory workflows and what this means in clinical practice.

Read more about the EXENT system here: https://www.thermofisher.com/bindingsite/wo/en/learning-resources/blog/thought-leadership/mass-spectrometry-myeloma-monitoring-blind-spot.html?nocache

Attending ADLM 2026? Come to our first micro-lecture today at booth #3501 ๐ŸŽค The EXENTโ„ข System: Delivering Clearer Insig...
28/07/2026

Attending ADLM 2026? Come to our first micro-lecture today at booth #3501

๐ŸŽค The EXENTโ„ข System: Delivering Clearer Insights in Multiple Myeloma

At 10am Dr Nick Paciaroni will be sharing some clinical data using the EXENT System and discussing how it redefines monoclonal protein testing and outcomes for patients.

Meet more of the Binding Site team attending ADLM 2026 begins today, and we are introducing our final group of experts ...
27/07/2026

Meet more of the Binding Site team attending

ADLM 2026 begins today, and we are introducing our final group of experts who will be representing Binding Site at this year's event.

Whether you're interested in monoclonal protein testing, clinical applications, or the latest laboratory innovations, our team is looking forward to meeting you.

Binding Site, part of Thermo Fisher Scientific, is now onsite and ready to engage with the laboratory community.At the T...
27/07/2026

Binding Site, part of Thermo Fisher Scientific, is now onsite and ready to engage with the laboratory community.

At the Thermo Fisher Scientific booth our team is discussing the latest innovations in monoclonal protein diagnostics.
Weโ€™ll be running live demos of the EXENTโ„ข System and Optiliteโ„ข Analyser throughout the congress

๐Ÿ“… Secure time with our team and book your demo slot here: https://www.thermofisher.com/bindingsite/wo/en/learning-resources/events/adlm.html

The introductions continue! Meet more of our Binding Site team attending With experts from across our business attendi...
25/07/2026

The introductions continue! Meet more of our Binding Site team attending

With experts from across our business attending ADLM 2026, we're excited to connect with customers, partners, and the wider laboratory community.

If you're heading to the event, come and meet the team at the Thermo Fisher Scientific booth. We look forward to sharing insights, answering your questions, and discussing the future of monoclonal protein testing.

Our ADLM 2026 Innovation and Technology Division Abstract Award-winning study highlights the reproducibility of the EXEN...
23/07/2026

Our ADLM 2026 Innovation and Technology Division Abstract Award-winning study highlights the reproducibility of the EXENTโ„ข system across five international clinical laboratories.

Demonstrating its potential to support greater consistency and confidence in M-protein testing across healthcare settings.

Visit Poster B-039 on 29 July at ADLM 2026 to learn more or hear Dr. Nick Paciaroni give a lightning talk on the topic during the INT division event (INT spectacular) on the 28 July, which is a ticket only event.

Or view the abstract here: https://l1nq.com/d6yu901

Meet some of the Binding Site team attending ๐Ÿ”ฌOur Binding Site experts are heading to ADLM 2026 and are ready to conne...
22/07/2026

Meet some of the Binding Site team attending ๐Ÿ”ฌ

Our Binding Site experts are heading to ADLM 2026 and are ready to connect, share insights, and discuss the latest in monoclonal protein testing.

From clinical applications to workflow innovation, come and meet the people driving progress. Stop by the Thermo Fisher Scientific booth and talk to the team.

Learn more about our ADLM workshop, micro-lectures & product demo's here: https://www.thermofisher.com/bindingsite/wo/en/learning-resources/events/adlm.html

Address

8 Calthorpe Road, Edgbaston
Birmingham
B151QT

Opening Hours

Monday 7:30am - 5pm
Tuesday 7:30am - 5pm
Wednesday 7:30am - 5pm
Thursday 7:30am - 5pm
Friday 7:30am - 5pm

Telephone

+441214569500

Website

Alerts

Be the first to know and let us send you an email when The Binding Site posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Binding Site:

Shortcuts

Share

Category